Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MedWellAI, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.31
0.28
0.45
1.85
6.55
3.86
0
0.59
Cost of revenue
0.24
1.01
1
0.92
3.87
2.7
3.93
Gross profit
0.07
-0.73
-0.54
0.93
2.68
-2.43
-3.93
Research and development
0.12
0.02
Selling and marketing
0
0.07
General and administrative
3.35
0.99
1.3
1.82
0.35
22.6
3.22
16
9.28
2.55
Operating expenses
3.47
1.01
6.2
3.92
0.47
22.6
3.37
22.7
Operating income
-3.47
-1.01
-6.14
-4.65
-1.01
-21.7
-0.69
-25.2
-9.07
-2.84
Interest expense
-0.15
0.21
0.66
0.44
0.02
0.28
0.08
0.05
Other non-operating income
0.56
-4.87
-0.07
-0.76
0.12
-0.29
-0.08
-0.11
Pre-tax income
-5.03
-1.76
-5.58
-9.51
-1.08
-22.4
-0.57
-25.5
-9.15
-2.95
Income tax
0
0
0
0
0
0
0
Income from continuing operations
-9.15
-2.95
Net income to minority interests
0
-0.17
Net income
-5.03
-1.76
-5.58
-9.51
-1.08
-22.4
-0.57
-25.5
-11.5
-3.61
EBITDA
-3.47
-6.08
-4.09
-0.44
-21.3
0.93
-21.6
-9.07
-2.81
EPS, basic
-0.67
-0.70
-0.02
-0.16
-0.01
-11.98
-2.72
EPS, diluted
-0.67
-0.70
-0.02
-0.16
-0.01
-11.98
-2.72
Shares, basic (weighted)
29.2
78.2
8.31
13.7
65.4
146
205
2.25
4.41
Shares, diluted (weighted)
29.2
317
8.31
13.7
65.4
146
205
2.25
4.41
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0
0.02
0.04
0.05
0.01
2.1
0.49
0.26
0.06
0.4
Short-term investments
0.25
0
Receivables
0
0
Inventory
0.11
Other current assets
0
0.01
0.01
0
0
0.2
0
0.01
0.25
0.01
Total current assets
0
0.3
0.17
0.08
0.01
11.1
0.49
0.71
2.6
0.42
Property, plant and equipment
0
0.63
1.04
0.45
3.16
13.3
5.3
0
0.04
Lease right-of-use assets
0
0.1
Goodwill
4.15
0
Intangible assets
0
0.05
Total assets
0.01
0.3
0.83
1.12
0.55
13.4
16.3
6.59
3.94
0.81
Accounts payable
0.03
0.03
0.03
0.04
0.08
0.03
0.06
0.29
0.13
0.12
Accrued liabilities
0.04
0.04
0.03
0.02
0.03
0
0.01
0.12
0.03
0.06
Deferred revenue
0
0
Total current liabilities
1.49
0.35
2.96
2.21
0.66
0.27
1.56
2.98
3.68
3.06
Long-term debt
0
Lease liabilities
0
0.08
Total liabilities
1.49
0.35
2.96
2.21
0.66
0.27
5.69
7.1
3.68
3.14
Total debt
0
Paid-in capital
3.64
5.84
9.29
19.9
21.9
48.4
56.8
72.6
81.2
82
Retained earnings
-5.16
-5.89
-11.5
-21
-22.1
-45.1
-46.2
-73.1
-85.1
88.7
Shareholders' equity
-0.45
-0.05
-2.13
-1.09
-0.11
8.96
10.6
-0.51
-3.87
-6.62
Minority interests
0
0.16
Total equity
-0.45
-0.05
-2.13
-1.09
-0.11
8.96
10.6
-0.51
-3.87
-6.46
Total liabilities and equity
0.01
0.3
0.83
1.12
0.55
13.4
16.3
6.59
3.94
0.81
Shares outstanding
32.7
5.21
8.96
29.8
103
194
1.66
2.86
5.06
6.19
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-5.03
-1.76
-5.58
-9.51
-1.08
0
0.57
25.5
-11.5
-3.78
Depreciation and amortization
0
0.06
0.55
0.58
0.41
1.62
3.6
0
0.03
Stock-based compensation
3.05
0.73
0.81
0.08
0
16.5
2.44
15.2
0
0.6
Change in receivables
0
0
Change in inventory
0.65
Change in payables
0.02
0.01
0.05
-0.28
0.03
0.24
-0.11
0.1
Cash from operations
-0.48
-0.27
-1.15
-0.71
-0.67
-1.57
0.06
-3.43
-4.13
-0.85
Capital expenditures
0.61
0.04
-0.12
-3.29
-0.07
0
0
-0
Acquisitions
0
-0.25
Purchases of investments
0.01
0
0.37
Sales and maturities of investments
0.05
0.71
Cash from investing
0.05
0.42
0.19
0.22
-9.12
-2.27
3.25
4.17
1.19
Stock issued
0.06
0.72
0
8.14
0
Cash from financing
0.43
0.23
0.76
0.53
0.41
12.8
0.6
-0.05
-0.24
0
Net change in cash
-0.04
0.01
0.03
0.01
-0.04
2.09
-1.61
-0.23
-0.2
0.34
Free cash flow
-0.54
-0.67
-0.79
-4.86
-0.02
-3.43
-4.13
-0.85
Interest paid
0.01
0.03
0
0
0
0.05
0.08
0.03
Income taxes paid
0
0
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.37 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-136.1%
Operating income / revenue.
EBITDA margin
-134.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-161.1%
Net income / revenue.
Operating cash flow margin
-26.0%
Cash from operations / revenue.
Return on assets (ROA)
-717.3%
Net income / average total assets.
Stock-based pay / revenue
10.9%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
2.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue CAGR, 3y
-55.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
5.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-79.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-63.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
8.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.02x
Current assets / current liabilities.
Quick ratio
0.02x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.02x
(Cash + short-term investments) / current liabilities.
Market cap + total debt - cash - short-term investments.
P/S
1.69x
Market cap / revenue.
EV/Sales
1.60x
Enterprise value / revenue.
Earnings yield
-95.4%
Net income / market cap (the inverse of P/E).
What was MedWellAI, Inc.'s revenue in fiscal 2025?
MedWellAI, Inc. reported revenue of $594.8K for fiscal 2025.
Was MedWellAI, Inc. profitable in fiscal 2025?
No. It reported a net loss of $3.6M.
How much free cash flow did MedWellAI, Inc. generate in fiscal 2025?
Cash from operations of $848.5K minus capital expenditures of $2.2K left free cash flow of -$850.8K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.